TWST241220C42500
- 2.92
- 0.000.00%
Twist Bioscience Newsroom
Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference
Twist Bioscience (TWST) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Wolfe Research Initiates Twist Bioscience(TWST.US) With Buy Rating, Announces Target Price $60
Why Twist Bioscience (TWST) Is the Worst ARK Stock to Buy According to Short Sellers
Express News | Twist Bioscience Corp : Guggenheim Raises Target Price to $58 From $53
We're Not Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn
The hidden winner in the USA election? Cathie Wood's ARKK hit a new high for the year, all thanks to these heavily weighted stocks!
The strong rise of ARKK is mainly attributed to the increase in its heavy holdings, Tesla, and cryptos-related companies, Coinbase and Robinhood.
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments
Twist Bioscience Named a Best Idea for 2025 at TD Cowen
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $58
Twist Bioscience Shares Are Trading Higher After Leerink Partners Maintained Its Hold Rating on the Stock.
Cautious Outlook for Twist Bioscience Amid Regulatory Changes and Competitive Pressures
Express News | Scorpion Capital- Remain Short on Twist Bioscience
AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care
Twist Bioscience Full Year 2024 Earnings: EPS Misses Expectations
Twist Bioscience Price Target Lowered to $52 From $55 at Barclays
Twist Bioscience Corporation (TWST): Among the Best Genomics Stocks to Buy Right Now
Twist Bioscience Is Maintained at Overweight by Barclays
Twist Bioscience Price Target Raised to $54.00/Share From $50.00 by Scotiabank